Acute Medicine | Cardiovascular | Diagnosis of endocarditis
Diagnosis of Endocarditis
Session Overview
Description
This session reviews Duke criteria and exceptions.
Learning Objectives
By the end of this session you will be able to:
- Identify major and minor Duke criteria
The diagnosis of endocarditis is clinical. It is essential to recognise that the disease process can affect multiple organs, with a variety of possible presentations. Familiarity with the Duke criteria for the diagnosis of infective endocarditis is important.
- Anaesthesia | Pharmacology | Pharmacokinetics prin...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-08-17
- Location:Online
- This session explains the variations in pharmacokinetics as observed in different anaesthetic patient populations.
- Anaesthesia | Pharmacology | Target controlled inf...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-08-17
- Location:Online
- This session will develop the three compartment model to include an effect-site and discuss its application to target-controlled infusions used for induction and maintenance of anaesthesia. The concept of context-sensitive half-time will be introduced.
- Anaesthesia | Pharmacology | Clearance and volume ...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-08-17
- Location:Online
- This session will discuss clearance and volume of distribution and methods used to estimate and measure these kinetic parameters.
- Anaesthesia | Pharmacology | Two- and three-compar...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-08-17
- Location:Online
- This session will develop pharmacokinetic modelling. The two- and three-compartment models will be introduced showing how the parameters described in a simple model are used in these more complicated models.
- Anaesthesia | Pharmacology | Introduction to pharm...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-08-17
- Location:Online
- This session will introduce pharmacokinetics and modelling. The simple one-compartment model will be described and reasons presented as to why such a model rarely describes drug behaviour.